First Trust Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $525M | Buy |
21,818,803
+1,395,845
| +7% | +$36.5M | 0.31% | 71 |
|
|
2026
Q1 | $573M | Buy |
20,422,958
+1,691,541
| +9% | +$45M | 0.41% | 41 |
|
|
2025
Q4 | $466M | Buy |
18,731,417
+495,755
| +3% | +$12.5M | 0.34% | 66 |
|
|
2025
Q3 | $465M | Buy |
18,235,662
+760,924
| +4% | +$18.8M | 0.35% | 56 |
|
|
2025
Q2 | $424M | Buy |
17,474,738
+755,066
| +5% | +$17.6M | 0.34% | 55 |
|
|
2025
Q1 | $424M | Buy |
16,719,672
+2,347,586
| +16% | +$61.4M | 0.38% | 42 |
|
|
2024
Q4 | $381M | Buy |
14,372,086
+2,426,546
| +20% | +$65.8M | 0.34% | 50 |
|
|
2024
Q3 | $346M | Sell |
11,945,540
-6,418
| -0.1% | -$187K | 0.33% | 56 |
|
|
2024
Q2 | $334M | Sell |
11,951,958
-2,396,215
| -17% | -$66M | 0.34% | 51 |
|
|
2024
Q1 | $398M | Sell |
14,348,173
-6,048,572
| -30% | -$168M | 0.4% | 38 |
|
|
2023
Q4 | $587M | Sell |
20,396,745
-1,197,755
| -6% | -$36.2M | 0.64% | 14 |
|
|
2023
Q3 | $716M | Buy |
21,594,500
+2,103,593
| +11% | +$74.4M | 0.85% | 3 |
|
|
2023
Q2 | $715M | Buy |
19,490,907
+8,960,028
| +85% | +$349M | 0.81% | 6 |
|
|
2023
Q1 | $430M | Buy |
10,530,879
+1,363,186
| +15% | +$58.9M | 0.5% | 20 |
|
|
2022
Q4 | $470M | Buy |
9,167,693
+3,424,236
| +60% | +$164M | 0.56% | 13 |
|
|
2022
Q3 | $251M | Sell |
5,743,457
-7,230
| -0.1% | -$351K | 0.33% | 50 |
|
|
2022
Q2 | $302M | Sell |
5,750,687
-2,158,978
| -27% | -$110M | 0.37% | 39 |
|
|
2022
Q1 | $409M | Buy |
7,909,665
+4,112,528
| +108% | +$213M | 0.42% | 27 |
|
|
2021
Q4 | $224M | Sell |
3,797,137
-598,029
| -14% | -$29.6M | 0.22% | 116 |
|
|
2021
Q3 | $189M | Sell |
4,395,166
-484,015
| -10% | -$21.4M | 0.2% | 133 |
|
|
2021
Q2 | $191M | Sell |
4,879,181
-985,506
| -17% | -$38.3M | 0.21% | 122 |
|
|
2021
Q1 | $213M | Sell |
5,864,687
-2,987,901
| -34% | -$106M | 0.26% | 89 |
|
|
2020
Q4 | $326M | Sell |
8,852,588
-189,383
| -2% | -$6.95M | 0.43% | 38 |
|
|
2020
Q3 | $315M | Buy |
9,041,971
+1,024,510
| +13% | +$35.9M | 0.5% | 30 |
|
|
2020
Q2 | $249M | Buy |
8,017,461
+3,133,548
| +64% | +$106M | 0.43% | 32 |
|
|
2020
Q1 | $151M | Buy |
4,883,913
+566,822
| +13% | +$19.3M | 0.34% | 44 |
|
|
2019
Q4 | $160M | Buy |
4,317,091
+1,058,513
| +32% | +$37.7M | 0.27% | 60 |
|
|
2019
Q3 | $111M | Buy |
3,258,578
+559,741
| +21% | +$20.4M | 0.21% | 94 |
|
|
2019
Q2 | $111M | Sell |
2,698,837
-2,249,247
| -45% | -$89.3M | 0.21% | 104 |
|
|
2019
Q1 | $199M | Buy |
4,948,084
+291,491
| +6% | +$11.7M | 0.4% | 33 |
|
|
2018
Q4 | $193M | Buy |
4,656,593
+695,361
| +18% | +$28.9M | 0.46% | 27 |
|
|
2018
Q3 | $166M | Sell |
3,961,232
-375,026
| -9% | -$14.4M | 0.31% | 44 |
|
|
2018
Q2 | $149M | Sell |
4,336,258
-285,962
| -6% | -$9.77M | 0.31% | 49 |
|
|
2018
Q1 | $156M | Buy |
4,622,220
+732,746
| +19% | +$25.2M | 0.36% | 42 |
|
|
2017
Q4 | $134M | Buy |
3,889,474
+184,163
| +5% | +$6.28M | 0.32% | 46 |
|
|
2017
Q3 | $126M | Sell |
3,705,311
-302,878
| -8% | -$9.73M | 0.32% | 45 |
|
|
2017
Q2 | $128M | Sell |
4,008,189
-778,769
| -16% | -$24.6M | 0.34% | 40 |
|
|
2017
Q1 | $155M | Sell |
4,786,958
-35,118
| -0.7% | -$1.11M | 0.43% | 28 |
|
|
2016
Q4 | $149M | Buy |
4,822,076
+309,993
| +7% | +$9.46M | 0.44% | 26 |
|
|
2016
Q3 | $145M | Buy |
4,512,083
+619,110
| +16% | +$20.7M | 0.43% | 23 |
|
|
2016
Q2 | $130M | Buy |
3,892,973
+700,472
| +22% | +$22.4M | 0.41% | 28 |
|
|
2016
Q1 | $89.8M | Buy |
3,192,501
+244,254
| +8% | +$6.98M | 0.29% | 58 |
|
|
2015
Q4 | $90.3M | Buy |
2,948,247
+685,532
| +30% | +$21.6M | 0.23% | 91 |
|
|
2015
Q3 | $67.4M | Sell |
2,262,715
-63,946
| -3% | -$2.05M | 0.2% | 112 |
|
|
2015
Q2 | $74M | Sell |
2,326,661
-2,047,565
| -47% | -$66.7M | 0.19% | 110 |
|
|
2015
Q1 | $144M | Buy |
4,374,226
+301,416
| +7% | +$9.58M | 0.42% | 30 |
|
|
2014
Q4 | $120M | Sell |
4,072,810
-302,333
| -7% | -$8.67M | 0.41% | 28 |
|
|
2014
Q3 | $123M | Buy |
4,375,143
+1,145,296
| +35% | +$32.1M | 0.48% | 10 |
|
|
2014
Q2 | $91M | Buy |
3,229,847
+1,869,453
| +137% | +$53.3M | 0.38% | 24 |
|
|
2014
Q1 | $41.5M | Sell |
1,360,394
-1,320,182
| -49% | -$39.4M | 0.18% | 105 |
|
|
2013
Q4 | $77.9M | Buy |
2,680,576
+64,742
| +2% | +$1.88M | 0.38% | 23 |
|
|
2013
Q3 | $71.3M | Buy |
2,615,834
+552,208
| +27% | +$15M | 0.39% | 24 |
|
|
2013
Q2 | $54.8M | Buy |
+2,063,626
| New | +$57M | 0.36% | 24 |
|
Other funds holding PFE
VCM
VPM
First Trust Advisors's PFE Position: Q2 2026 in Review
First Trust Advisors increased its Pfizer (PFE) stake by 6.8% in Q2 2026, buying an estimated $36.5M and bringing the position to 21,818,803 shares worth $525M. The position accounts for 0.31% of the portfolio, ranked #71.
First Trust Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $716M in Q3 2023. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First Trust Advisors held 21,818,803 shares of Pfizer worth $525M as of Q2 2026.
- First Trust Advisors bought 1,395,845 Pfizer shares in Q2 2026, an estimated $36.5M.
- Pfizer made up 0.31% of First Trust Advisors's portfolio in Q2 2026, its #71 holding.
- First Trust Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- First Trust Advisors's Pfizer position peaked at $716M in Q3 2023.
- 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.